Dr. Reddy’s Laboratories Ltd.’s Drops Efforts on Novartis AG Drug Clone

Dr Reddys Laboratories has dropped plans of developing a generic version of Novartis anti-fungal skin/nails treatment drug Lamifil (terbinafine hydrochloride), which has estimated sales of $1 billion…
Read the full story: BioSpace.com Featured News